下一代测序时代上尿路尿路上皮癌的分子特征:当前文献的系统综述
该系统综述基于PubMed、Scopus和Web of Science检索,纳入46篇文献,评估上尿路尿路上皮癌(UTUC)的基因组测序和蛋白质组数据。综述比较了散发性与遗传性UTUC、UTUC与膀胱癌的分子差异,并讨论了FGFR3、TP53及微卫星不稳定等相关通路。结论指出UTUC与膀胱癌分子事件可共享亦可不同,分子亚型因部位而异,需进一步明确表观基因组和蛋白质组特征。
要点
- UTUC与膀胱癌组织学相似但分子改变存在部位特异性差异。
- FGFR3、TP53及微卫星不稳定等通路与UTUC生物学相关。
- 散发性与遗传性UTUC及马兜铃酸暴露相关分子谱存在差异。
核心结论
- UTUC与膀胱癌的分子事件可共享也可不同,分子亚型因部位而异。
- UTUC的分子改变频率和富集改变支持其独特性,需精准医学策略。
- 需进一步定义UTUC的表观基因组和蛋白质组特征及其临床行为机制。
研究设计与样本
- 共纳入46篇文献:13项全基因组改变研究、18项基因或microRNA表达谱研究、3项蛋白质组学研究、1项全基因组DNA甲基化研究、14项通路改变模式研究。
主要发现
- UTUC与膀胱癌组织学外观相似,但病因和临床表型差异与特征性分子改变一致。
- 综述强调了散发性与遗传性UTUC之间、UTUC与膀胱癌之间以及马兜铃酸暴露相关分子谱的差异。
- 讨论了FGFR3、TP53改变及微卫星不稳定等与UTUC生物学相关的分子通路。
临床怎么用
- UTUC与膀胱癌分子事件可共享或不同,临床应考虑部位特异性分子分型。
- UTUC的独特性支持对该罕见肿瘤类型采取精准医学策略。
局限性
- 研究受肿瘤和患者异质性限制。
- 纳入研究使用了不同的检测平台。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: While upper tract urothelial carcinoma (UTUC) share histological appearance with bladder cancer (BC), the former has differences in etiology and clinical phenotype consistent with characteristic molecular alterations. OBJECTIVE: To systematically evaluate current genomic sequencing and proteomic data examining molecular alterations in UTUC. EVIDENCE ACQUISITION: A systematic review using PubMed, Scopus, and Web of Science was performed in December 2019 according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses statement. EVIDENCE SYNTHESIS: A total of 46 publications were selected for inclusion in this report, including 13 studies assessing genome-wide alterations, 18 studies assessing gene expression or microRNA expression profiles, three studies assessing proteomics, one study assessing genome-wide DNA methylation, and 14 studies evaluating distinct pathway alteration patterns. Differences between sporadic and hereditary UTUC, and between UTUC and BC, as well as molecular profiles associated with exposure to aristolochic acid are highlighted. Molecular pathways relevant to UTUC biology, such as alterations in FGFR3, TP53, or microsatellite instability, are discussed. Our findings are limited by tumor and patient heterogeneity and different platforms used in the studies. CONCLUSIONS: Molecular events in UTUC and BC can be shared or distinct. Consequently, molecular subtypes differ according to location. Further work is needed to define the epigenomic and proteomic features of UTUC, and understand the mechanisms by which they shape the clinical behavior of UTUC. PATIENT SUMMARY: We report the current data on the molecular alterations specific to upper tract urothelial carcinoma (UTUC), resulting from novel genomic and proteomic technologies. Although UTUC biology is comparable with that of bladder cancer, the rates and UTUC-enriched alterations support its uniqueness and the need for precision medicine strategies for this rare tumor type.
引用
- Hassler MR, Bray F, Catto JWF, et al. Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature. Eur Urol. 2020. PMID: 32571725. doi:10.1016/j.eururo.2020.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。